WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017062520) RATIONAL COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/062520    International Application No.:    PCT/US2016/055594
Publication Date: 13.04.2017 International Filing Date: 05.10.2016
IPC:
A61K 45/06 (2006.01), A61K 31/337 (2006.01), A61K 31/52 (2006.01), A61K 31/704 (2006.01), A61P 35/00 (2006.01)
Applicants: MEMORIAL SLOAN KETTERING CANCER CENTER [US/US]; 1275 York Avenue New York, New York 10065 (US)
Inventors: CHIOSIS, Gabriela; (US).
TALDONE, Tony; (US).
SHRESTHA, Liza; (US).
KOREN, John; (US).
GOMES-DAGAMA, Erica M.; (US).
RODINA, Anna; (US)
Agent: REARICK, John P.; (US).
AUGST, Alexander D.; (US).
BUTEAU, Kristen C.; (US).
CAHILL, John J.; (US).
HAULBROOK, William R.; (US).
LUCA, Cassandra G.; (US).
JARRELL, Brenda Herschbach; (US).
LI, Xiaodong; (US).
LYON, Charles E.; (US).
MEDINA, Rolando; (US).
MONROE, Margo R.; (US).
NGUYEN, Suzanne P.; (US).
NIHAN, Danielle M.; (US).
PACE, Nicholas J.; (US).
PELLIGRINO, Jeffrey S.; (US).
PYSHER, Paul A.; (US).
REESE, Brian E.; (US).
ROHLFS, Elizabeth M.; (US).
SAHR, Robert N.; (US).
SCHONEWALD, Stephanie L.; (US).
SHAIKH, Nishat A.; (US).
SHINALL, Michael A.; (US).
SMITH, Maria C.; (US).
SUH, Su Kyung; (US).
VETTER, Michael L.; (US).
VRABLIK, Tracy L.; (US).
WANG, Gang; (US)
Priority Data:
62/237,470 05.10.2015 US
Title (EN) RATIONAL COMBINATION THERAPY FOR THE TREATMENT OF CANCER
(FR) POLYTHÉRAPIE RATIONELLE POUR LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The disclosure provides methods of using inhibitors of chaperone proteins, such as HSP90 inhibitors, in combination with agents that increase proteotoxic stress on tumor cells or agents that induce a biochemical rewiring of the chaperome. The proteotoxic agents are administered prior to administration of the chaperone proteins to achieve synergistic activity.
(FR)La présente invention concerne des procédés d'utilisation d'inhibiteurs de protéines chaperon, tels que des inhibiteurs de HSP90, en association avec des agents qui augmentent le stress protéotoxique sur des cellules tumorales ou des agents qui induisent un recâblage biochimique du chaperon. Les agents protéotoxiques sont administrés préalablement à l'administration des protéines chaperon pour obtenir une synergie d'activité.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)